NCFC(SH:600889) Zheng Quan Zhi Xing·2025-08-27 16:41Core Viewpoint - Nanjing Chemical Fiber Co., Ltd. is undergoing a significant asset swap, issuing shares, and cash payments for asset purchases, which has raised inquiries from the Shanghai Stock Exchange regarding the valuation and impairment of assets involved in the transaction [1][2]. Group 1: Asset Impairment and Valuation - The company has reported continuous negative net profits over the last three years, with impairment amounts of 32.60 million, 77.30 million, and 266.22 million yuan respectively [2][3]. - The assets being disposed of have a book value of 557.38 million yuan and an assessed value of 729.27 million yuan, with the increase in value primarily attributed to land use rights [2][3]. - Significant impairments were noted for other assets, particularly a 153.62 million yuan impairment for Shanghai Yueke [2][3]. Group 2: Financial Data and Analysis - The total impairment losses for the last three years were 32.60 million yuan in 2022, 77.30 million yuan in 2023, and 266.22 million yuan in 2024, with the main contributors being subsidiaries such as Jinling Biological and Shanghai Yueke [3][4]. - Specific impairment losses for 2024 included 44.90 million yuan for inventory, 176.02 million yuan for fixed assets, and 45.77 million yuan for construction in progress [4][5]. - The company is required to disclose detailed information regarding the impairment projects, amounts, and the rationale behind the impairment assessments [3][4]. Group 3: Independent Review and Compliance - The independent financial advisor, lawyer, accountant, and appraiser are mandated to verify and provide clear opinions on the asset disposal and impairment matters [3][4]. - The company must ensure that the arrangements during the transition period of the disposed assets are favorable for protecting minority investors' interests [3][4].